CANLI
Yükleniyor Veriler getiriliyor…
/ Makaleler / Scopus Detay
Scopus YÖKSİS Eşleşti

Analysis of Pediatric Intensive Care Unit Admissions for Crimean-Congo Hemorrhagic Fever in Turkey

Journal of Pediatric Infectious Diseases · Eylül 2020

YÖKSİS DOI Eşleşmesi Bulundu

Bu Scopus makalesi YÖKSİS veritabanında da kayıtlı. Aşağıda YÖKSİS verilerini görebilirsiniz.

YÖKSİS Kayıtları
Analysis of Pediatric Intensive Care Unit Admissions for Crimean–Congo Hemorrhagic Fever in Turkey
Journal of Pediatric Infectious Diseases · 2020 SCI-Expanded
PROFESÖR RESUL YILMAZ →

Makale Bilgileri

DergiJournal of Pediatric Infectious Diseases
Yayın TarihiEylül 2020
Cilt / Sayfa15 · 242-247
Özet Objective  The aim of this study was to determine the clinical characteristics, course of disease, and outcomes of patients admitted to our pediatric intensive care unit (PICU) for Crimean-Congo hemorrhagic fever (CCHF). Methods  Data of all patients with CCHF who were admitted to PICU during a 3-year period and whose diagnosis was confirmed by serological methods or polymerase chain reaction were retrospectively reviewed. Their presenting characteristics, treatments, and outcomes were extracted from the hospital's electronic database. Disease severity scoring was performed using the severity scoring index and severity grading score system. Results  The data of 22 of 123 patients with suspected CCHF who were admitted to PICU were evaluated. Among them, 68.2% were males and mean age of all patients was 13.4 ± 2.2 years. The average length of stay of 10 patients was >10 days. On average, 3.72 units of platelet suspension per patient was transfused. In the course of the disease, the highest laboratory values were reached on day 3 of admission. Conclusion  Poor CCHF outcome depends on thrombocytopenia severity, prolonged coagulation tests, high-liver enzyme levels, and disseminated intravascular coagulation. Poor outcomes can be avoided by CCHF awareness and preparedness, early diagnosis of the disease, and supportive treatment with appropriate fluid and blood product transfusion. Randomized controlled trials on prophylactic transfusion and ribavirin use are needed.

Yazarlar (5)

1
Resul Yilmaz
2
Erhan Karaaslan
3
Suleyman Ekrem Albayrak
4
Ali Gul
5
Tuba Kasap

Anahtar Kelimeler

Crimean-Congo hemorrhagic fever pediatric intensive care unit Turkey

Kurumlar

Selçuk Üniversitesi
Selçuklu Turkey
Simav Doc. Dr. Ismail Karakuyu State Hospital
Kutahya Turkey
Tokat Gaziosmanpaşa Üniversitesi
Tokat Turkey

Metrikler

1
Atıf
5
Yazar
3
Anahtar Kelime

Sistemimizdeki Yazarlar